701
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug

, , , , , , & show all
Pages 261-272 | Received 14 Jun 2022, Accepted 18 Oct 2022, Published online: 26 Jan 2023

Figures & data

Figure 1 Chemical structure of simvastatin.

Figure 1 Chemical structure of simvastatin.

Table 1 Composition of various formulations of SEDDSs for simvastatin

Table 2 Composition of different formulations of S-SEDDSs for simvastatin

Table 3 Composition of different formulations of simvastatin self-emulsifying tablets

Table 4 Solubility of simvastatin in oils and their combination with Tween 60

Figure 2 (A) FTIR spectra of pure simvastatin, (B) simvastatin solution prepared in a mixture of olive oil and Tween 60, and (C) simvastatin solution prepared in castor oil and Tween 60.

Figure 2 (A) FTIR spectra of pure simvastatin, (B) simvastatin solution prepared in a mixture of olive oil and Tween 60, and (C) simvastatin solution prepared in castor oil and Tween 60.

Table 5 Emulsification time and cloud point of self-emulsified formulations

Table 6 Results of precompression evaluation of powder blends for different formulations of SEDDS-based tablets

Table 7 Physical parameters and mechanical strength of SEDDS-based tablets

Figure 3 Disintegration time of different formulations of simvastatin self-emulsified tablets. Disintegration time was determined according to USP for six tablets (n=6), using purified water as media held at 37°±2°C.

Figure 3 Disintegration time of different formulations of simvastatin self-emulsified tablets. Disintegration time was determined according to USP for six tablets (n=6), using purified water as media held at 37°±2°C.

Figure 4 Dissolution rate from different formulations of simvastatin self-emulsified tablets.

Figure 4 Dissolution rate from different formulations of simvastatin self-emulsified tablets.

Figure 5 Comparison of cumulative drug release after 15 (Q15 min) and 30 min (Q30 min).

Figure 5 Comparison of cumulative drug release after 15 (Q15 min) and 30 min (Q30 min).